Neurologic clinical trial - Argenx-113-1902 OLE - Adhere +

Status:

Start-up

ARGX-113-1902, Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Drug

Efgartigimod PH20 SC

Trial Type

OLE

Condition

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)